NCT06314919View on ClinicalTrials.gov

A Study to Evaluate the Efficacy and Safety of Fixed-Dose Combination of Pitavastatin/Ezetimib

RecruitingOBSERVATIONAL
Enrollment

8,606

Participants

Timeline

Start Date

March 15, 2024

Primary Completion Date

June 30, 2026

Study Completion Date

June 30, 2026

Conditions
Primary HypercholesterolemiaMixed Dyslipidemia
Trial Locations (1)

Unknown

RECRUITING

Ewha Womans University Seoul Hospital, Seoul

Sponsors
All Listed Sponsors
lead

Boryung Pharmaceutical Co., Ltd

INDUSTRY